A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors

Condition:   Solid Tumors
Interventions:   Drug: Cobimetinib;   Drug: Atezolizumab
Sponsor:   Hoffmann-La Roche
Not yet recruiting - verified August 2017

http://ift.tt/2xqTHeM